Subject
Neurology (clinical),Neurology,General Medicine
Reference42 articles.
1. Alemtuzumab vs. interferon beta-1a in early multiple sclerosis;Coles;N. Engl. J. Med.,2008
2. Center for Drug Evaluation and Research, Food and Drug Administration, 2019. Treatment of Relapsing forms of Multiple Sclerosis (RMS). Available from: https://www.accessdata.fda.gov/drugsatfda_docs/nda/2019/022561Orig1s000ClinPharmR.pdf.
3. Precision medicine in the multiple sclerosis clinic: Selecting the right patient for the right treatment;Bose;Mult. Scler.,2020
Cited by
24 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献